Hui‐Ling Chiou

4.6k total citations
94 papers, 3.8k citations indexed

About

Hui‐Ling Chiou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hui‐Ling Chiou has authored 94 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 25 papers in Oncology and 25 papers in Cancer Research. Recurrent topics in Hui‐Ling Chiou's work include Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (10 papers) and Autophagy in Disease and Therapy (7 papers). Hui‐Ling Chiou is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (10 papers) and Autophagy in Disease and Therapy (7 papers). Hui‐Ling Chiou collaborates with scholars based in Taiwan, United States and Czechia. Hui‐Ling Chiou's co-authors include Shun‐Fa Yang, Shu‐Chen Chu, Pei‐Ni Chen, Yih‐Shou Hsieh, Chui-Liang Chiang, Ming‐Ju Hsieh, Wu‐Hsien Kuo, Yih‐Shou Hsieh, Yi‐Hsien Hsieh and Mu‐Kuan Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Hui‐Ling Chiou

93 papers receiving 3.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Hui‐Ling Chiou 1.9k 701 598 545 441 94 3.8k
Yih‐Shou Hsieh 1.8k 1.0× 794 1.1× 515 0.9× 369 0.7× 358 0.8× 124 4.1k
Yong Lin 2.0k 1.1× 819 1.2× 628 1.1× 386 0.7× 226 0.5× 67 3.7k
Chi‐Cheng Lu 2.7k 1.5× 709 1.0× 575 1.0× 602 1.1× 328 0.7× 140 5.0k
Fajun Yang 2.4k 1.3× 609 0.9× 523 0.9× 576 1.1× 251 0.6× 55 4.5k
Tzong‐Der Way 2.1k 1.2× 573 0.8× 660 1.1× 277 0.5× 337 0.8× 116 3.9k
Hong Cai 3.3k 1.8× 603 0.9× 928 1.6× 336 0.6× 388 0.9× 184 5.8k
Johannes M. Breuss 2.5k 1.3× 776 1.1× 675 1.1× 257 0.5× 291 0.7× 66 5.6k
Alena Líšková 1.9k 1.0× 806 1.1× 502 0.8× 212 0.4× 489 1.1× 52 3.8k
Shu‐Chen Chu 1.6k 0.9× 606 0.9× 414 0.7× 250 0.5× 613 1.4× 96 3.7k
Pavel Uhrín 1.8k 1.0× 498 0.7× 734 1.2× 210 0.4× 278 0.6× 70 4.7k

Countries citing papers authored by Hui‐Ling Chiou

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ling Chiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ling Chiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ling Chiou more than expected).

Fields of papers citing papers by Hui‐Ling Chiou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ling Chiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ling Chiou. The network helps show where Hui‐Ling Chiou may publish in the future.

Co-authorship network of co-authors of Hui‐Ling Chiou

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ling Chiou. A scholar is included among the top collaborators of Hui‐Ling Chiou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ling Chiou. Hui‐Ling Chiou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Chien‐Hsing, et al.. (2024). Sorafenib, a Tyrosine Kinase Inhibitor, Synergistically Enhances the Ferroptosis Effects of Asiatic Acid in Hepatocellular Carcinoma Cells. Environmental Toxicology. 40(1). 79–87. 2 indexed citations
2.
Lin, Chia‐Liang, et al.. (2023). Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation. Cancer Letters. 583. 216584–216584. 10 indexed citations
3.
Hsieh, Ming‐Hong, Hui‐Ling Chiou, Chia‐Yi Lee, et al.. (2023). Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma. Journal of Cancer. 14(3). 360–366.
4.
Wang, Kai, et al.. (2022). Melatonin inhibits NaIO3-induced ARPE-19 cell apoptosis via suppression of HIF-1α/BNIP3-LC3B/mitophagy signaling. Cell & Bioscience. 12(1). 133–133. 22 indexed citations
5.
Wu, Minhua, Chia‐Liang Lin, Hui‐Ling Chiou, et al.. (2017). Praeruptorin A Inhibits Human Cervical Cancer Cell Growth and Invasion by Suppressing MMP-2 Expression and ERK1/2 Signaling. International Journal of Molecular Sciences. 19(1). 10–10. 85 indexed citations
6.
Lin, Chiao‐Wen, Ying‐Erh Chou, Hui‐Ling Chiou, et al.. (2014). Pterostilbene suppresses oral cancer cell invasion by inhibiting MMP-2 expression. Expert Opinion on Therapeutic Targets. 18(10). 1109–1120. 45 indexed citations
7.
Hsieh, Ming-Ju, et al.. (2014). MicroRNA Gene Polymorphisms and Environmental Factors Increase Patient Susceptibility to Hepatocellular Carcinoma. PLoS ONE. 9(2). e89930–e89930. 45 indexed citations
8.
Yeh, Chao‐Bin, et al.. (2014). Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma. BMC Complementary and Alternative Medicine. 14(1). 141–141. 16 indexed citations
9.
Yeh, Chao‐Bin, Ming-Ju Hsieh, Yih-Shou Hsieh, et al.. (2012). Terminalia catappaExerts Antimetastatic Effects on Hepatocellular Carcinoma through Transcriptional Inhibition of Matrix Metalloproteinase-9 by Modulating NF-κB and AP-1 Activity. Evidence-based Complementary and Alternative Medicine. 2012. 1–11. 36 indexed citations
10.
Hsieh, Ming‐Ju, et al.. (2010). The Involvement of Mitochondrial-related Caspase Pathway in HCV NS5A-induced Apoptosis of Huh-7 Cells. 22(3). 102–109. 1 indexed citations
11.
Cheng, Ya‐Wen, Ming‐Fang Wu, John Wang, et al.. (2007). Human Papillomavirus 16/18 E6 Oncoprotein Is Expressed in Lung Cancer and Related with p53 Inactivation. Cancer Research. 67(22). 10686–10693. 112 indexed citations
12.
Shih, Chuen‐Ming, Yao-Ling Lee, Hui‐Ling Chiou, et al.. (2006). Association of TNF-α polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer. 52(1). 15–20. 90 indexed citations
13.
Chen, Pei‐Ni, Wu‐Hsien Kuo, Chui-Liang Chiang, et al.. (2006). Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. Chemico-Biological Interactions. 163(3). 218–229. 193 indexed citations
14.
Tsai, Horng-Jyh, Yawen Peng, Long‐Yau Lin, et al.. (2005). An association between human papillomavirus 16/18 deoxyribonucleic acid in peripheral blood with p16 protein expression in neoplastic cervical lesions. Cancer Detection and Prevention. 29(6). 537–543. 7 indexed citations
15.
Hsieh, Yih-Shou, et al.. (2005). Relationship between matrix metalloproteinase-2 activity and cystatin C levels in patients with hepatic disease. Clinical Biochemistry. 38(7). 632–638. 12 indexed citations
16.
Hsieh, Yih‐Shou, Shun‐Fa Yang, Hui‐Ling Chiou, & Dong‐Yih Kuo. (2005). Activations of c-fos/c-jun signaling are involved in the modulation of hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine-mediated appetite suppression. Toxicology and Applied Pharmacology. 212(2). 99–109. 21 indexed citations
17.
Yang, Shun‐Fa, et al.. (2004). Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients. Clinica Chimica Acta. 354(1-2). 91–99. 55 indexed citations
18.
Chen, Bo-Yie, Han‐Hsin Chang, Hui‐Ling Chiou, & David Pei‐Cheng Lin. (2004). Influenza-B-Virus-Induced Eye and Brain Malformations during Early Chick Embryogenesis and Localization of the Viral RNA in Specific Areas. Journal of Biomedical Science. 11(2). 266–274. 5 indexed citations
19.
Chou, Fen‐Pi, et al.. (2002). Effect of hemodialysis on the plasma level of type IV collagenases and their inhibitors. Clinical Biochemistry. 35(5). 383–388. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yih‐Shou Hsieh Breakdown of academic impact, for papers by Yong Lin Breakdown of academic impact, for papers by Chi‐Cheng Lu Breakdown of academic impact, for papers by Fajun Yang Breakdown of academic impact, for papers by Tzong‐Der Way Breakdown of academic impact, for papers by Hong Cai Breakdown of academic impact, for papers by Johannes M. Breuss Breakdown of academic impact, for papers by Alena Líšková Breakdown of academic impact, for papers by Shu‐Chen Chu Breakdown of academic impact, for papers by Pavel Uhrín
Rankless by CCL
2026